MAAT PHARMA
Kjøper 6,38
Selger 6,44
ESG ACHIEVEMENTS AND GOALS
Patients are our priority. MaaT Pharma aims to become the source of Microbiome excellence providing patients with safe and innovative medicines. The Company develops products from sustainable biological matters, driving optimal impact of Microbiome.
We are committed to our patients and to the protection of human health by respecting environmental protection, respecting our employees, and ensuring good governance practices. Our way of working every day is driven by the 4 guidelines below :
- Innovate and raise awareness to deliver better care,
- Contribute to employees-growth within a people-oriented ecosystem,
- Place ethics and transparency at the core of the Company's strategy,
- Control and measure our impact on the environment.
We, MaaTiens, are committed to this approach.
DOCUMENTS
ENVIRONMENTAL INDICATORS
| Indicator | Unit | 2023 | 2022 |
|---|---|---|---|
| Total GHG emissions (CO2 eq) | Ton | 2 394 | 1 733 |
| Carbon footprint (total GHG emissions / enterprise value) | Ton / Million (EUR) | 25,16 | 19,16 |
| GHG intensity (total GHG emissions / revenue) | Ton / Million (EUR) | 1 074,51 | 1 211,89 |
| Total energy consumption | kWh | 14 799 | 13 352 |
| Energy intensity (total energy consumption / revenue) | MWh / Million (EUR) | 6,64 | 9,34 |
| Hazardous waste | Ton | 3 | 2 |
FINANCIAL INDICATORS
| Indicator | Unit | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Annual revenue | Thousand (EUR) | 2 228 | 1 430 | 972 |
| Enterprise value at fiscal year-end | Thousand (EUR) | 95 156 | 90 452 | 137 755 |